# Jurriën M. ten Berg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jurrien-m-ten-berg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 52,263 |
| Field | Antiplatelet Therapy and Cardiovascular Diseases |
| h-index | 85 |
| i10-index | 338 |
| Last Known Institution | Maastricht University Medical Centre |
| OpenAlex ID | https://openalex.org/A5007123733 |
| ORCID iD | https://orcid.org/0000-0001-5192-886X |
| Works | 683 |

## Researcher papers

- [2014 ESC/EACTS Guidelines on myocardial revascularization](https://scholariq.org/papers/2014-esc-eacts-guidelines-on-myocardial-revascularization/)
- [2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)](https://scholariq.org/papers/2022-esc-guidelines-on-cardio-oncology-developed-in-collaboration-with-the-2/)
- [2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)](https://scholariq.org/papers/2024-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in/)
- [2024 ESC Guidelines for the management of chronic coronary syndromes](https://scholariq.org/papers/2024-esc-guidelines-for-the-management-of-chronic-coronary-syndromes/)
- [Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation](https://scholariq.org/papers/dual-antithrombotic-therapy-with-dabigatran-after-pci-in-atrial-fibrillation/)
- [A Genotype-Guided Strategy for Oral P2Y <sub>12</sub> Inhibitors in Primary PCI](https://scholariq.org/papers/a-genotype-guided-strategy-for-oral-p2y-sub-12-sub-inhibitors-in-primary-pci/)
- [2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)](https://scholariq.org/papers/2022-esc-guidelines-on-cardio-oncology-developed-in-collaboration-with-the/)
- [Bleeding and stent thrombosis on P2Y<sub>12</sub>-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention](https://scholariq.org/papers/bleeding-and-stent-thrombosis-on-p2y-sub-12-sub-inhibitors-collaborative/)

## Researcher topics

- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)

## Researcher university

- [Maastricht University Medical Centre](https://scholariq.org/institutions/maastricht-university-medical-centre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.